GLP-1 Without Insurance: How to Get It and What to Pay

Summary: The cheapest legal way to get a GLP-1 without insurance in 2026 is a LillyDirect Self Pay Zepbound vial or NovoCare Wegovy direct from Novo Nordisk, both bought with a real prescription from a US-licensed prescriber.

This content is for informational purposes only and is not medical advice. Always consult a qualified healthcare provider before starting, changing, or stopping any medication.

If you are paying cash in 2026, the cheapest legal way to get a GLP-1 in the United States is to buy directly from the manufacturer. LillyDirect Self Pay ships Zepbound single-dose vials at $349 for the 2.5 mg starter and $499 for the higher maintenance doses ^[1]. NovoCare Pharmacy ships Wegovy pens at $199 for your first prescription and $499 every refill after that ^[2]. Both require a valid US prescription. Neither asks about your insurance. Neither runs a credit check.

Everything else marketed as "GLP-1 without insurance" sits on a sliding scale between those two anchor prices and a list of compromises that include compounded drug from pharmacies operating in a gray zone, telehealth subscriptions with monthly fees on top of the medication, and patient assistance programs with strict income caps. Below is the full map. Pick the path that matches your situation.

The fast answer

Why insurance fails GLP-1 patients

Commercial insurers cover GLP-1 medications for type 2 diabetes most of the time. They cover them for obesity, with no other diagnosis, perhaps a third of the time, and most of those plans add a body mass index floor, a documented weight-loss attempt requirement, and prior authorization steps. Medicare does not pay for GLP-1s when the prescribed indication is weight loss. Medicaid coverage varies state by state, with most states refusing to cover anti-obesity drugs.

Even when a plan covers the drug class, the copay is often higher than the manufacturer self-pay price. Patients hit a $250 specialty-tier copay, find out the deductible resets in January, and quietly switch to LillyDirect. That is the market reality in 2026, and it is what the manufacturer cash programs were designed to capture.

LillyDirect Self Pay: the Zepbound vial path

Eli Lilly sells Zepbound single-dose vials directly to patients through LillyDirect Pharmacy. The 2026 prices, set by Lilly and listed on the LillyDirect storefront, are $349 for the 2.5 mg vial four-pack (one month) and $499 for the 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg four-packs ^[1]. You pay per month. There is no annual membership.

How it works:

1. You need a Zepbound prescription written for vials specifically, not pens. Your existing prescriber can write it. If you do not have a prescriber, LillyDirect lists telehealth partners (Cove, Form Health, FlyteHealth, others) that will run a video visit and issue the prescription if you qualify. Telehealth fees are separate from the drug price and run roughly $25 to $75 for the initial visit.
2. Your prescriber sends the prescription to LillyDirect Pharmacy.
3. You pay Lilly by card. The vials ship to your door in a cold-chain box. You also receive a separate shipment of needles and syringes.
4. Refills repeat the same flow each month.

Vials require you to draw the dose yourself with a U-100 insulin syringe. Lilly includes instructions and provides supplies. The clinical content of the vial is the same tirzepatide that comes in a Zepbound pen, manufactured in the same Lilly facilities, FDA approved under the same label. The only differences are the delivery format and the price.

NovoCare Pharmacy: the Wegovy pen path

Novo Nordisk runs the equivalent program for semaglutide. NovoCare Pharmacy ships Wegovy pens to patients paying cash. The 2026 pricing is $199 for the first month and $499 per month for every refill thereafter ^[2]. The starter price is a real introductory rate, not a coupon, and it applies regardless of dose.

Wegovy is only sold as a pre-filled pen. There is no vial format available through Novo Nordisk for the US market in 2026, so the price floor for direct-from-Novo semaglutide is $499 a month once the starter period ends. Ozempic, the type 2 diabetes form of semaglutide, is also available through NovoCare at similar pricing if you have a diabetes diagnosis, but the indication on the prescription has to match.

The process mirrors LillyDirect. You need a prescription. Novo lists telehealth partners on the NovoCare site if you do not have a prescriber. You pay Novo directly. Pens ship to your home in a cold-chain box. Refills run monthly.

Two practical notes:

• Wegovy pens are dose-locked. A 0.25 mg pen delivers only 0.25 mg doses. To titrate up you switch pens. NovoCare ships you the correct pen for your current dose.
• The $199 starter price is per fill, not per dose. If your prescriber writes a one-month supply, you pay $199 once, then $499 from month two forward.

Patient Assistance Programs: free medication if you qualify

Both manufacturers run Patient Assistance Programs for low-income US patients with no insurance or with Medicare Part D only. These programs ship medication free of charge to people who clear the income screen.

Novo Nordisk Patient Assistance Program covers Wegovy, Ozempic, and Saxenda for US citizens or legal residents enrolled in Medicare Part D or with no insurance, at household incomes at or below 200 percent of the federal poverty level ^[5]. For a household of one in 2026, that ceiling is roughly $31,000 in annual income. For a household of four it is roughly $64,000.

Lilly Cares covers Zepbound and Mounjaro for similar populations, with a household income ceiling at or below 300 percent of the federal poverty level, which is the more generous of the two.

Both programs now require a Medicaid denial letter as part of the application, since the manufacturers want documentation that other safety-net options were exhausted first. You apply on the manufacturer site, submit pay stubs or a tax return, and wait two to four weeks for an eligibility decision. If approved, the medication ships to your prescriber's office or your home depending on the program, and you re-enroll annually.

PAP is the cheapest legal path to a GLP-1 if you qualify. The income limits are the gate.

GoodRx and pharmacy discount cards: why they barely move the needle

GoodRx, SingleCare, Optum Perks, and the other pharmacy discount cards have published prices for Wegovy, Ozempic, Mounjaro, and Zepbound, but the discounted retail price is still north of $900 a month at every major US pharmacy chain. The coupon shaves $50 to $150 off the sticker. It does not bring the price into the same league as LillyDirect or NovoCare.

Where these cards do help: if your prescriber writes you a prescription for an older GLP-1 like liraglutide (Victoza brand or the Teva authorized generic), GoodRx can price that under $400 a month at some chains. Liraglutide is a daily injection, not weekly, and produces less weight loss than semaglutide or tirzepatide in head-to-head data, but it is the one GLP-1 with a generic on the US market.

For semaglutide and tirzepatide specifically, the discount-card math does not compete with buying direct from the manufacturer. Check the price before you fill, but do not plan on it as your primary strategy.

Compounded GLP-1s: the post-shortage reality

From 2022 through late 2024 the FDA listed both semaglutide and tirzepatide as drugs in shortage. That listing legally opened the door for 503A and 503B compounding pharmacies to produce copies of the molecules for individual patients with a prescription. A telehealth industry grew up around that window, advertising compounded semaglutide for $199 a month and compounded tirzepatide for $299 to $399, often without the patient ever seeing a Lilly or Novo branded product.

The FDA declared the tirzepatide shortage resolved in late 2024 and the semaglutide shortage resolved in early 2025 ^[4]. With the shortage off the books, the legal basis for compounding "essentially a copy" of either branded drug evaporated. The FDA's enforcement guidance through 2025 and into 2026 made clear that mass-marketed compounded GLP-1s are no longer protected by the shortage exemption ^[3].

What remains legal:

• A licensed prescriber can still order a compounded GLP-1 for a specific patient when there is a documented clinical reason that the FDA-approved product will not work, such as a patient allergic to an excipient in the branded pen.
• Compounded products that are not "essentially copies" of the branded drug, such as semaglutide combined with B12, occupy a contested middle ground that the FDA is actively litigating.
• Compounded peptides for true individual patient need, prepared in PCAB-accredited pharmacies under a real prescription, remain available.

What is no longer legal at scale:

• A telehealth provider mass-marketing compounded semaglutide or tirzepatide to anyone who fills out a questionnaire.
• An online pharmacy shipping research-grade peptides to consumers without a prescription.
• A spa or wellness clinic selling vials of compounded GLP-1 over the counter to walk-in customers.

The compounded market did not vanish overnight. Some telehealth providers continue to offer compounded products under the "personalized formulation" framing, and some 503A pharmacies are still shipping. The risk has shifted to the patient. You no longer know if your supplier will be raided next month, if the formulation has been tested, or if your provider's medical license will survive the FDA enforcement cycle. The FDA's warning communications list real harms tied to compounded GLP-1s, including dose errors caused by mismatched concentrations, contaminated vials, and counterfeit products marketed as semaglutide that contained no semaglutide at all ^[3].

Legitimate telehealth: what you are actually paying for

A telehealth GLP-1 program bundles three things: the medical visit, the prescription, and (often) the medication. The price you see advertised covers some combination of those. Read the breakdown before you sign up.

The legitimate models in 2026:

• Prescription-only telehealth. A prescriber writes you a Zepbound or Wegovy prescription that you send to LillyDirect or NovoCare. You pay the telehealth provider $25 to $200 for the visit and ongoing care. You pay the manufacturer separately for the drug. Total monthly cost: telehealth fee plus $349 to $499 for the drug.
• Bundled FDA-approved. The telehealth provider handles the visit and ships you Zepbound or Wegovy through their partner pharmacy at a marked-up rate that often exceeds buying direct. Useful for convenience, rarely cheapest.
• Bundled compounded. The telehealth provider handles the visit and ships you compounded semaglutide or tirzepatide at $149 to $399 a month. Lower price, regulatory risk described in the previous section.

The pattern to watch: a $99 or $149 starter price almost always escalates after the first month or two. Read the fine print on the recurring billing rate, the dose escalation pricing, and the cancellation policy before you authorize the first charge. Several large telehealth providers in this space charge a $79 to $200 monthly platform fee on top of the medication, so the headline "$199 GLP-1" can become $278 to $399 once everything posts.

How to actually qualify for a GLP-1 prescription without insurance

Most prescribers, including the telehealth physicians staffing LillyDirect and NovoCare partner platforms, follow the same clinical criteria the FDA labels list:

• Zepbound and Wegovy for weight management: BMI of 30 or higher, or BMI of 27 or higher with at least one weight-related comorbidity (hypertension, type 2 diabetes, dyslipidemia, obstructive sleep apnea, cardiovascular disease).
• Mounjaro and Ozempic for type 2 diabetes: a documented diagnosis of type 2 diabetes, usually with a recent hemoglobin A1c value.

Without insurance you still need a prescription. The prescriber will ask for height, weight, and a brief medical history. Telehealth visits are typically a five to fifteen minute video call. A previous failed weight-loss attempt strengthens the chart note for Wegovy or Zepbound but is not always required. If you have lab work from the past year, upload it. If you do not, some telehealth platforms will order basic labs (CBC, CMP, A1c, lipid panel) at a partner LabCorp or Quest location for $50 to $100, paid out of pocket.

You do not need to "shop" your diagnosis. If your BMI does not meet the label threshold and you do not have a qualifying comorbidity, a legitimate prescriber will not write you a Wegovy or Zepbound script regardless of what you pay.

Costs across the full year

These are drug costs only. Telehealth visit fees, lab work, sharps containers, and needles add roughly $50 to $300 over a year depending on the platform.

Side comparison: what each path looks like in practice

The cheapest legal path, as a decision tree

Walk down the list. Stop at the first row where the answer is yes.

1. Is your household income at or below 200 to 300 percent of the federal poverty level? Apply to Lilly Cares (Zepbound, Mounjaro) or the Novo Nordisk Patient Assistance Program (Wegovy, Ozempic) ^[5]. If approved, your cost is $0.
2. Do you have commercial insurance, even if it does not cover GLP-1s? Check the manufacturer savings card on the LillyDirect or NovoCare site. If the savings card brings your copay below $250, use it. If your insurance excludes the drug class entirely, savings cards do not apply, skip this step.
3. Are you willing to use vials and draw your dose with an insulin syringe? Order Zepbound through LillyDirect Self Pay. $349 for the 2.5 mg starter month, $499 thereafter ^[1].
4. Do you specifically want semaglutide instead of tirzepatide? Order Wegovy through NovoCare Pharmacy. $199 first month, $499 ongoing ^[2].
5. Are you eligible for daily liraglutide and willing to inject every day? Ask your prescriber for generic liraglutide and price it on GoodRx. Roughly $400 a month at major US chains.
6. None of the above and you cannot afford $499 a month? This is where compounded telehealth lives. Understand the regulatory and quality risks, choose a PCAB-accredited pharmacy, verify the prescriber holds an active license in your state, and start at the lowest dose. The FDA has explicitly warned that the safest low-cost GLP-1 is the FDA-approved one you can afford to stay on long term ^[3].

Common questions about getting a GLP-1 without insurance

How much does a GLP-1 cost without insurance in 2026?

$349 to $499 a month through LillyDirect Zepbound vials, $199 for the first month and $499 ongoing through NovoCare Wegovy, $0 through manufacturer Patient Assistance Programs if you qualify, $149 to $399 through compounded telehealth with regulatory risk, or $1,000 to $1,400 a month at retail pharmacy.

Can I get GLP-1 medications without insurance and without a doctor?

No. Every legal GLP-1 in the United States, including LillyDirect, NovoCare, and any compounded version, requires a prescription from a US-licensed prescriber. Telehealth visits make the prescription step fast and cheap, but the prescription itself is non-negotiable.

How do I get GLP-1 medication without insurance?

Get a prescription from a primary care provider or a telehealth platform, then send it to LillyDirect Pharmacy for Zepbound or NovoCare Pharmacy for Wegovy. Pay the manufacturer directly. The vials or pens ship to your home in a cold-chain box.

Do I need insurance for GLP-1 weight loss?

No. The manufacturer self-pay programs were designed for uninsured patients and for insured patients whose plans exclude weight-loss drugs. You still need a valid prescription, but you do not need insurance to buy from LillyDirect or NovoCare.

Are there GLP-1 providers no insurance required?

Yes. The manufacturer pharmacies (LillyDirect, NovoCare) and most telehealth weight-loss platforms accept cash payment without checking for insurance. The cheapest legal path is to combine a telehealth or in-person prescription with direct purchase from the manufacturer.

Is compounded GLP-1 still legal without insurance?

Compounded GLP-1s lost the FDA shortage exemption when the semaglutide and tirzepatide shortages were declared resolved. Some 503A pharmacies still ship under individual patient prescriptions, but the legal and quality landscape is narrower than it was in 2024. Verify pharmacy accreditation and prescriber licensure before you buy.

What is the cheapest GLP-1 without insurance for type 2 diabetes?

For diabetes specifically, Ozempic through NovoCare runs in the same range as Wegovy. Generic liraglutide (Victoza authorized generic) priced on GoodRx is often the cheapest GLP-1 for diabetes patients without insurance, at roughly $400 a month, though it requires daily injection instead of weekly.

Will GoodRx help me afford a GLP-1?

Marginally. GoodRx coupons trim $50 to $150 off the retail price of Wegovy, Ozempic, Zepbound, and Mounjaro, but the discounted retail price is still over $900 a month, well above the LillyDirect and NovoCare self-pay prices. GoodRx is most useful for generic liraglutide and for ancillary medications, not for branded GLP-1s.

How long can I stay on a GLP-1 without insurance at these prices?

Indefinitely, if you can sustain the monthly cost. Both Lilly and Novo Nordisk price their self-pay programs as ongoing maintenance, not introductory promotions (the NovoCare $199 first month is the only widely advertised intro rate). Re-evaluate annually since the manufacturers do adjust prices.

Can I switch from compounded to FDA-approved without restarting titration?

Yes, in most cases. If you are stable on a 5 mg compounded tirzepatide weekly dose, your prescriber can transition you to a Zepbound 5 mg vial without going back to the 2.5 mg starter. Discuss the switch with your prescriber and confirm the dose matches what the brand product delivers.

What to do this week

If you are uninsured and you want a GLP-1, the action list is short. Pick LillyDirect or NovoCare based on whether you want tirzepatide or semaglutide. Get a prescription. Pay the manufacturer. Skip the noise about $99 telehealth offers and gray-market compounded vials unless the math literally does not work any other way, and even then, take an hour first to apply to Lilly Cares or the Novo Nordisk PAP. Free medication beats cheap medication.